Introduction {#Sec1}
============

Genetic tools to achieve specific genome modifications are essential for reverse genetics and could also provide powerful means to develop genetically modified organisms in biotechnology. Gene targeting via homology-directed recombination has been established as a primary tool for targeted genome modification in certain systems (Capecchi [@CR9]; Smithies [@CR61]). This process essentially involves a transfer of donor DNA (which contains homologous DNA sequences to target loci of the genome of interest) into cells and the use of this donor DNA by the cell's homology-directed recombination machinery to exchange genetic information between the donor DNA and chromosomal target loci (Vasquez et al. [@CR69]). Although gene targeting has been extremely useful, this process is limited to model systems in which donor DNA can be efficiently delivered and endogenous DNA repair machinery allows recombination between the donor DNA and the endogenous target loci with high frequency. Indeed, these requirements have limited gene targeting primarily to mouse and yeast systems. The frequency of homologous recombination (HR) events between foreign donor DNA and its chromosomal target can be dramatically enhanced by introducing a specific double strand break (DSB) in the chromosomal target in most research models (Johnson and Jasin [@CR22]; Puchta et al. [@CR51]). Although several different approaches for inducing a site-specific DSB in a cell have been suggested, zinc finger nucleases (ZFNs) have emerged as a versatile and universal tool to enable gene targeting in various organisms (Porteus and Carroll [@CR50]).

ZFNs are chimeric DNA restriction enzymes that consist of a custom-designed zinc finger (ZF) DNA-binding domain and the nonspecific nuclease domain from the FokI restriction enzyme (Porteus and Carroll [@CR50]). Because ZF domains can be engineered to bind to a pre-determined DNA sequence at a genomic locus of interest, ZFNs can be used to introduce DSBs at specific genomic sites in a targeted manner, thereby improving gene targeting efficiency (Bibikova et al. [@CR6]). However, the versatility of ZFNs as a tool for the targeted manipulation of the genome goes far beyond the improvement of HR-mediated gene targeting.

In a eukaryotic cell, DSBs are mainly repaired by two evolutionarily conserved DSB repair pathways, HR and non-homologous end joining (NHEJ) (Wyman and Kanaar [@CR73]). By exploiting these two DSB repair pathways, one can use ZFN-induced DSBs to manipulate the genome in a specific manner. With their versatility and universal nature, ZFNs have successfully supported genome engineering in cultured cells and various animal models, including *C. elegans* and *D. melanogaster*, which have long been used for genetic studies (Beumer et al. [@CR3]; Bibikova et al. [@CR5]; Carroll et al. [@CR12]; Kim et al. [@CR24]; Morton et al. [@CR42]; Santiago et al. [@CR57]; Urnov et al. [@CR67]). In addition, ZFNs also have emerged as robust and reproducible tools for genome engineering in important model systems in which traditional reverse genetic methodologies are not easily applicable. These systems include rat, zebrafish, silk worm, sea urchin, model plants, and crops (Doyon et al. [@CR16]; Geurts et al. [@CR19]; Meng et al. [@CR38]; Ochiai et al. [@CR43]; Osakabe et al. [@CR45]; Shukla et al. [@CR59]; Takasu et al. [@CR64]; Townsend et al. [@CR66]; Zhang et al. [@CR74]).

In this review, we will first describe different approaches for developing ZFNs for specific target sequences. Then we will explore how ZFNs were used to achieve genome engineering in recent studies, emphasizing their uses in plants.

Engineering ZFNs {#Sec2}
================

The structure of ZFNs {#Sec3}
---------------------

ZFNs are created by combining the nuclease domain of the FokI type II S restriction enzyme with engineered ZF DNA-binding domains (Chandrasegaran and Smith [@CR13]; Kim et al. [@CR23]). Within this structure, ZF DNA-binding domains---composed of an array of multiple C2H2 zinc fingers---determine the DNA binding specificity, thus guiding ZFNs to their target site (Fig. [1](#Fig1){ref-type="fig"}). The nuclease domain provides the enzymatic activity that cleaves DNA strands (Durai et al. [@CR17]; Porteus and Carroll [@CR50]). Because one ZF module recognizes a 3-base pair (bp) DNA subsite, a ZFN with an array of 3 or 4 ZFs recognizes and binds to a sequence of 9 or 12 nucleotides. Since the cleavage activity of the FokI nuclease domain requires dimerization, a pair of ZFNs forms a site-specific endonuclease enzyme. Thus, a target site of a pair of three-finger ZFNs consists of two 9-bp recognition sequences flanking a spacer 5 or 6 bp in length. Thus, the target site of a ZFN pair is expected to be very rare---if not unique---in a genome, enabling ZFNs to introduce site-specific DSBs.Fig. 1Structure of ZFNs. Schematic representation of ZFNs bound to their target sites. These nucleases are created by fusing an engineered ZF DNA binding domain to the DNA cleavage domain of the FokI type IIS restriction enzyme. An array of 3 ZFs (*shaded ovals*) for each ZFN protein will recognize a target sequence on DNA (*shaded boxes*). The binding of two ZFNs on the target DNA with a spacer (5/6 bp) in the middle will trigger the dimerization of the ZFN nuclease domains and the cleavage of the target DNA

The specificity of this system has recently been increased further through the development of an improved ZFN architecture (Miller et al. [@CR39]; Szczepek et al. [@CR63]). When a pair of ZFNs is expressed together in a cell with the aim of digesting a target site, homodimerization of each ZFN could result in possible off-target site cleavages. To overcome this caveat, two groups have independently developed FokI nuclease domain variants that are engineered to show cleavage activity only as a heterodimer. The use of such obligatory heterodimeric FokI nuclease variants has greatly improved the specificity and reduced the cellular toxicity of ZFNs.

ZF binding domains and different methods of building custom-designed ZF arrays {#Sec4}
------------------------------------------------------------------------------

ZF DNA-binding domains are among the most abundant DNA-binding domains encoded in higher eukaryotic genomes (Klug [@CR26]). Such domains are composed of a tandem array of multiple ZF modules in which each ZF recognizes a 3 bp DNA subsite (Wolfe et al. [@CR70]). Importantly, individual ZF modules retain their DNA-binding specificities in the context of artificially constructed multi-finger ZF proteins. This observation provoked the idea that one could use a directory of ZF modules, each recognizing one of the 64 possible 3-bp DNA subsites, to build an artificial ZF DNA binding domain that could bind to any DNA sequence (Pabo et al. [@CR46]). To this end, in the last 15 years many research groups have undertaken efforts to isolate naturally occurring ZF modules with various sequence specificities, as well as to use rational, combinatorial approaches to engineer ZF modules with altered DNA binding specificities. Such efforts have established a directory of ZFs that recognize many of the 64 possible 3-bp DNA subsites (Bae et al. [@CR2]; Lee et al. [@CR27]). These ZFs have been successfully used to build custom-designed DNA-binding domains for artificial transcription factors that can regulate biologically and clinically important genes in various organisms (Jamieson et al. [@CR21]; Park et al. [@CR47], [@CR48]). During the course of this work, several different methods of building new ZF DNA binding domains using ZF modules have been devised. Currently, three different methods are used to construct novel ZFNs: modular assembly, cell-based selection, and a proprietary method used by Sangamo Biosciences (Carroll et al. [@CR11]; Kim et al. [@CR25]; Maeder et al. [@CR34]; Urnov et al. [@CR68]; Wright et al. [@CR72]).

The traditional modular-assembly method involves a simple directory-based assembly of preselected ZFs as building blocks to construct multi-finger ZF arrays via standard recombinant DNA technology (Carroll et al. [@CR11]). There are several in silico tools (Kim et al. [@CR24]; Mandell and Barbas [@CR35]; Sander et al. [@CR55]) and sources of ZF modules (Bae et al. [@CR2]; Segal et al. [@CR58]; Wright et al. [@CR72]) to facilitate the modular assembly of ZFNs. Modularly assembled ZF arrays can be tested for their DNA-binding activities using standard assays that analyze DNA--protein interactions. Alternatively, the arrays can be assembled to form ZFNs that can be directly tested for their ability to induce DSBs at their target sites in the genome or a reporter construct. Reported success rates of modularly assembled ZFNs vary greatly, ranging from 6 to 30% depending on the study (Kim et al. [@CR24], [@CR25]; Lee et al. [@CR28]; Ramirez et al. [@CR52]). It should be noted that we have found that the careful selection and use of reliable modules consistently improves the success rates of modularly assembled ZFNs (Lee et al. [@CR28]) (Kim et al. [@CR76]). Modularly assembled ZFNs have been successfully used for genome engineering in various systems, including cultured mammalian cells, *C. elegans*, *D. melanogaster*, tobacco, and*Arabidopsis* (Beumer et al. [@CR3]; Bibikova et al. [@CR5]; Kim et al. [@CR24]; Morton et al. [@CR42]; Osakabe et al. [@CR45]; Siekmann et al. [@CR60]; Townsend et al. [@CR66]). With its simple procedure, coupled with well-established assays to test the activity of ZFNs, the modular-assembly method provides an easily accessible and reliable approach for rapidly generating and screening many ZFN pairs to target a specific sequence. Commercial services for the modular assembly and activity validation of ZFNs are also available from ToolGen, Inc. (<http://www.toolgen.com>).

A proprietary method used by Sangamo Biosciences is based on a principle similar to that of simple modular assembly, except that an archive of validated two-finger modules is used to assemble longer ZF arrays (Moore et al. [@CR41]). Although ZFNs made by this approach have been successfully used to engineer the genomes of cultured mammalian cells, animals, and plants (Cost et al. [@CR14]; Doyon et al. [@CR16]; Geurts et al. [@CR19]; Liu et al. [@CR30]; Moehle et al. [@CR40]; Orlando et al. [@CR44]; Santiago et al. [@CR57]; Shukla et al. [@CR59]; Urnov et al. [@CR67]), detailed information about the two-finger archive is not publically accessible. Instead, ZFNs developed by this approach are commercially available from Sigma-Aldrich (<http://www.sigma.com>), which licensed this technology from Sangamo; however, they are not available for use in plants because of an exclusive licensing agreement between Sangamo and Dow Agrosciences.

More recently, a cell-based selection approach for building site-specific ZFNs, termed the Oligomerized Pool ENgineering (OPEN) method, was developed (Maeder et al. [@CR33]; Maeder et al. [@CR34]). In this approach, pools of ZFs that are selected to bind different 3-bp DNA subsites are established from a library of ZFs with random mutations at their DNA-contacting residues using an *E. coli* two-hybrid selection system. Using a web-based analysis tool, a small number of candidate ZFN sites within a given target sequence are selected and a library of three-finger arrays for each target half site is constructed (Sander et al. [@CR56]). Then, using an *E. coli* two-hybrid selection system, three-finger arrays that bind to the 9-bp target sequence are selected and further analyzed. Selected three-finger arrays are assembled to form ZFNs, and their ability to introduce DSBs at the target site is determined. ZFNs created using the OPEN approach have been successfully used for genome engineering in cultured mammalian cells, zebrafish, tobacco, and*Arabidopsis* (Foley et al. [@CR18]; Maeder et al. [@CR33]; Townsend et al. [@CR66]; Zou et al. [@CR75]). This method, however, is both labor intensive and time consuming, because a few rounds of *E. coli*-based selection steps are required before making ZFNs. Furthermore, this method is limited to the production of three-finger ZFNs but not four-finger ZFNs; the complexity of four-finger arrays is about 100 times greater than that of three-finger arrays, and cannot be covered by the cell-based method. Four-finger ZFNs, in general, are more specific and reliable than are three-finger ZFNs (Lee et al. [@CR28]).

Targeted genome engineering using ZFNs {#Sec5}
======================================

DSBs pose a uniquely high threat to the integrity of the genetic information of a cell. Not only can the unfaithful repair of a DSB result in unwanted modifications of genetic information at the site of the DSB, but a failure to repair such a break could also lead to the loss of larger chromosomal fragments (Agarwal et al. [@CR1]). Thus, eukaryotic cells have evolved elaborate mechanisms to repair DSBs faithfully and efficiently. Two major mechanisms of DSB repair are known, NHEJ and HR. A site-specific DSB induced by ZFNs will trigger the repair process by NHEJ or HR, both of which can be exploited to achieve targeted genome engineering such as gene knockout and gene addition.

Targeted genome engineering via NHEJ {#Sec6}
------------------------------------

NHEJ is a rapid and efficient DSB repair mechanism that involves a simple ligation of the two DNA ends that result from a DSB (Lieber [@CR29]). The protein machinery of the canonical NHEJ pathway provides a mechanism to hold the two DNA ends in close physical proximity, trim the DNA ends to prepare them for subsequent ligation, and enzymatically ligate the two DNA ends to complete the repair process. Overall, the NHEJ mechanism is highly accurate and efficient in the repair of DSBs. The innate nature of NHEJ that lacks the use of an intact copy (a homologous sequence) to restore genetic information at DSBs, however, result in the formation of sporadic unfaithful repair products with the signature of small nucleotide deletions or insertions (indels).

Thus, if the ZFN target site is within a protein-coding region, small indels that arise from an unfaithful repair of ZFN-induced DSBs will likely result in a frameshift mutation in the target gene and thus a truncation of the target protein (Porteus and Carroll [@CR50]). NHEJ-mediated knockout of a target gene by ZFNs has some advantages over the HR-mediated gene knockout process by ZFNs. First, the frequency of NHEJ-mediated repair of DSBs is generally much higher than that of HR-mediated DSB repair. This is because NHEJ is a preferred DSB repair mechanism in higher eukaryotic cells. Additionally, the faithful repair of ZFN-induced DSBs will result in the restoration of the ZFN target site. In contrast, small indels created by unfaithful NHEJ will destroy the ZFN target site. Thus, while a cell is expressing ZFNs, the ZFN target site is likely to experience multiple rounds of digestion and repair, which will substantially increase the occurrence of NHEJ-mediated small indels. Another important advantage of the NHEJ-mediated gene knockout procedure is that, unlike the HR-mediated process, it does not require the simultaneous delivery of donor DNA with ZFNs into the cell.

NHEJ-mediated gene knockout using ZFNs has been extremely successful in animal models and cultured mammalian cells. In particular, the direct injection of mRNA encoding ZFNs into one-cell embryos has provided an efficient and rapid approach to establish gene knockout animal models (Remy et al. [@CR53]). Initially reported in*Drosophila*, this method has recently been successfully used in higher metazoan systems like zebrafish and rat, two important animal models for human diseases (Beumer et al. [@CR4]; Carbery et al. [@CR10]; Doyon et al. [@CR16]; Foley et al. [@CR18]; Geurts et al. [@CR19]; Mashimo et al. [@CR37]; Meng et al. [@CR38]). Using this approach, the efficient delivery of ZFNs is ensured. In addition, because ZFNs are delivered to a one-cell embryo from which a whole organism originates, one can expect a high rate of target gene knockout among somatic and germ line cells of direct offspring, expediting the process of establishing knockout animals, as compared to traditional gene targeting methods in mouse embryonic cell lines.

NHEJ-mediated gene knockout in cultured mammalian cells has been achieved by the transient expression of ZFNs via various gene delivery methods. In cells of a variety of species and origins, chemical transfection, electroporation, and integrase-deficient lentivirus-mediated delivery of DNA/RNA for ZFN expression have supported efficient gene knockout via NHEJ (Kim et al. [@CR24]; Lombardo et al. [@CR32]; Maeder et al. [@CR34]; Santiago et al. [@CR57]). The frequency of gene knockout using this approach ranged widely, from 1 to 50%. This high frequency of gene knockout by transient ZFN expression allowed researchers to isolate single cell-derived knockout clones without using any drug-mediated selection process. Indeed, this process was so efficient that a research group was able to knockout three genes in Chinese hamster ovary (CHO) cells by simple repetition of ZFN expression and single-clone isolation processes (Liu et al. [@CR30]).

In addition to the creation of simple gene knockouts, NHEJ-mediated repair of ZFN-induced DSBs can be exploited to achieve more complex and elaborate genome engineering (Fig. [2](#Fig2){ref-type="fig"}). First, the repair of two DSBs---each specifically induced by ZFNs via NHEJ---produces a subset of cells with chromosomal variations that involve the loss of genetic information between the two DSB sites (if the two DSB sites are on the same chromosome) and a translocation between two chromosomes (if the two DSB sites are on different chromosomes) (Brunet et al. [@CR7]; Lee et al. [@CR28]; Liu et al. [@CR30]; Petolino et al. [@CR49]; Sollu et al. [@CR62]). Second, small DNA fragments with appropriate overhang structures that are codelivered into cells with ZFNs can be incorporated into the DSB site with relatively high frequency (Orlando et al. [@CR44]) (Fig. [2](#Fig2){ref-type="fig"}a). Thus, the targeted addition of genetic information into the genome is possible using ZFNs via NHEJ. Yet to be applied in broader research models, these additional applications in targeted genome engineering suggest that ZFNs can be used to achieve a range of genomic variations, beyond simple gene knockouts, that have been found in comparative genomics research. In addition, ZFN-mediated large chromosomal deletions can allow the removal of a cluster of homologous and redundant genes in a single step.Fig. 2ZFN-mediated targeted genome engineering via NHEJ. **a** Gene knockout and DNA insertion. A DSB created by a pair of ZFNs stimulates the error-prone nonhomologous end joining (NHEJ) pathway, and the target gene can be disrupted by small indels induced by NHEJ repair (*left pathway*). Small DNA fragments delivered into the cell can be captured into the target site of a DSB induced by ZFNs via NHEJ (*right pathway*). **b** Gene deletion. The NHEJ repair of two concurrent DSBs flanking a target gene is induced by two ZFN pairs, which can give rise to targeted deletions of genes between the two sites

HR-mediated targeted genome engineering by ZFNs {#Sec7}
-----------------------------------------------

Homology-directed DSB repair involves the use of template DNA with homology to a DSB locus to restore genetic information in an error-free manner (San Filippo et al. [@CR54]). Even without inducing site-specific DSBs, foreign DNA transferred by researchers into cells can trigger the HR process between target and donor DNA to achieve gene targeting. This process, however, is extremely inefficient in most systems, with the exception of mouse embryonic stem cells and yeast. Site-specific DSBs at the gene targeting site have been proven to enhance the frequency of gene targeting greatly (100- to 10,000-fold) in various cells (Johnson and Jasin [@CR22]). Thus, ZFNs can be used to enable HR-mediated genome engineering when they are delivered into cells together with appropriately designed donor DNA (Porteus and Carroll [@CR50]) (Fig. [3](#Fig3){ref-type="fig"}). Like classical gene targeting, HR-mediated gene knockout using ZFNs enables researchers to use a drug resistance mediated selection scheme for isolating the small number of cells that have undergone the desired gene-targeting event. The efficient addition of up to 8 kb of genetic information from donor DNA into the ZFN target site via HR has also been reported (Moehle et al. [@CR40]). Additionally, because HR involves the faithful transfer of genetic information from donor DNA to the DSB site, researchers can achieve gene correction and gene editing, which are very difficult, if not impossible, with the NHEJ-mediated process. In fact, the first application of ZFNs at endogenous target loci in cultured human cells was to use ZFNs to correct inherited mutations in the human IL2RG gene that causes severe immune deficiency (Urnov et al. [@CR67]). More recently, ZFNs have supported efficient gene targeting and gene insertion at various target loci in human embryonic stem cells and induced pluripotent stem cells (Hockemeyer et al. [@CR20]; Zou et al. [@CR75]). Together, these studies suggest that ZFNs could be used for gene and cell therapy for inherited monogenic disorders.Fig. 3ZFN-mediated targeted genome engineering via HR. The repair of ZFN-induced DSBs via the HR pathway can be exploited to induce gene correction, gene knockout, and gene addition using properly designed donor DNA

Targeted genome engineering using ZFNs in plants {#Sec8}
================================================

Initial reports on the feasibility of ZFN-mediated genome engineering in plants used a previously characterized ZFN whose target sequence was artificially incorporated into a plant genome. In the first report, through the use of*Agrobacterium*-mediated gene delivery,*Arabidopsis* was engineered to carry a ZFN with a QQR zinc finger domain under the regulation of a heat-inducible promoter as well as a target site for the QQR ZFN homodimer (Lloyd et al. [@CR31]). The integrity of the QQR ZFN target site was analyzed in seven of these transgenic*Arabidopsis* lines, which were induced to express ZFN by heatshock. This analysis showed that 1.7--19.6% of the target sites contained ZFN-induced mutations. Among the mutagenized sites, 78% showed simple deletions of 1--52 bp, 13% showed simple insertions of 1--4 bp, and the rest showed more complex rearrangements, with both deletions and insertions. This study was followed by a report on successful HR-mediated reporter gene correction using ZFNs in tobacco (Wright et al. [@CR71]). To test if the ZFNs could enhance HR events in this species, the authors first carefully established a transgenic tobacco line carrying a defective version of a reporter gene that consisted of a fusion between sequences encoding b-glucuronidase (GUS) and neomycin phosphotransferase (NPTII), which confers resistance to kanamycin. This fusion reporter had a deletion of 600 bp at the fusion site and an insertion of a Zif268 ZFN binding site. When protoplasts from this transgenic tobacco line were transformed with donor DNA to restore the activity of the GUS:NTPII reporter gene, no GUS+ and kanamycin-resistant colonies were obtained. However, when the same donor DNA was transformed with Zif268 ZFN expression plasmids, double-positive colonies were recovered at a frequency of \~1 × 10^−4^. Further analysis estimated that 20% of these GUS+/Kan-resistant cells contained a legitimate target structure that resulted solely from the intended HR event, whereas the other cells contained additional accompanying DNA rearrangements. Together, these two studies demonstrated the possibility of ZFN-mediated genome engineering via NHEJ and HR in plants.

Since these reports, many research groups have developed methods to construct and deliver ZFNs and reporter systems to test the activity of ZFNs in plants (Cai et al. [@CR8]; de Pater et al. [@CR15]; Tovkach et al. [@CR65]). However, the real breakthrough in the application of ZFNs to plant research occurred in 2009, when endogenous genomic loci in tobacco and maize were successfully engineered using ZFNs (Maeder et al. [@CR33]; Shukla et al. [@CR59]; Townsend et al. [@CR66]) (Table [1](#Tab1){ref-type="table"}).Table 1ZFN-mediated engineering of endogenous genes in plantsPlantTarget geneZFN deliveryZFN developmentGenome engineeringReferenceTobaccoSurA and BElectroporationOPENNHEJ (gene knockout)Maeder et al. ([@CR34])TobaccoSurA and BElectroporationOPEN, modular assemblyHR (gene correction)Townsend et al. ([@CR66])*Zea mays*IPK1Whisker-mediated transformationTwo-finger modulesHR (gene knockout by selection marker addition)Shukla et al. ([@CR59])TobaccoCHN50*Agrobacterium*Two-finger modulesHR (gene knockout by selection marker addition)Cai et al. ([@CR8])*Arabidopsis*ABI4, NHEJ*Agrobacterium*Modular assemblyNHEJ (gene knockout)Osakabe et al. ([@CR45])*Arabidopsis*ADH1, TT4*Agrobacterium*OPENNHEJ (gene knockout)Zhang et al. ([@CR74])

Successful ZFN-mediated gene knockouts in tobacco were first achieved via NHEJ on the acetolactate synthase genes SuRA and SuRB (Maeder et al. [@CR33]). Among 66 transgenic plants generated from protoplasts that stably expressed a pair of ZFNs targeting both the SuRA and SuRB genes, three plants contained mutations in SuRA, and one plant was a homozygous mutant. No mutant SuRB allele was detected. In a subsequent study, the endogenous tobacco SuRA and SuRB genes were also efficiently engineered using ZFNs via an HR-mediated mechanism (Townsend et al. [@CR66]). For this purpose, additional ZFN pairs targeting the SuRA gene were developed using the modular assembly and OPEN methods and validated in a yeast-based reporter assay. The abilities of functional SuRA ZFN pairs to induce site-specific small indels via NHEJ upon expression in tobacco protoplasts were compared by pyrosequencing of the ZFN target site. Although site-specific mutagenesis by transient expression of ZFNs in protoplasts occurred at very low efficiency, this approach has enabled the comparison of ZFN activities on their endogenous targets in plant cells. The authors then constructed gene-correction donor DNA containing known missense mutations in the SuRA gene that confer herbicide resistance to tobacco. When this donor DNA was transformed together with ZFN expression plasmids into tobacco protoplasts, herbicide-resistant cells induced by an HR event between the target loci and donor DNA were obtained at a frequency of 0.2\~4%. HR-mediated gene addition was also reported for tobacco (Cai et al. [@CR8]). In this study, ZFNs targeting the CHN50 gene were developed and used to knock in a herbicide-tolerance gene (PAT). Both the ZFN expression vectors and the donor DNA were delivered into tobacco BY2 suspension culture cells using*Agrobacterium*. 5--10% of the selected plants were found to have undergone ZFN-induced targeted gene insertion at the CHN50 locus. Because the CHN50 gene displays robust expression in tobacco cells in suspension culture at the stationary phase, this locus could provide a safe harbor for gene addition for the high and stable expression of recombinant proteins under these conditions.

Plants in which ZFNs can be used for HR-mediated gene modifications include species beyond the model plant systems. Recently, this approach was used to produce maize plants with IPK1 mutations. The IPK1 gene encodes inositol-1,3,4,5,6-pentakisphosphate 2-kinase, which catalyzes the final step in phytate biosynthesis. Knockout of IPK1 is expected to render an agriculturally and environmentally beneficial phenotype in maize (Shukla et al. [@CR59]). Multiple ZFN pairs were constructed to target the IPK1 gene. Appropriate HR donor DNA for the targeted insertion of a herbicide-tolerance gene (PAT), with or without an autonomous promoter, were also constructed for each ZFN pair. The delivery of IPK1-targeted ZFNs together with the corresponding donor DNA successfully resulted in the production of herbicide-tolerant calli with site-specific insertion of the PAT gene. The use of autonomous donor DNAs for the targeted insertion of the PAT gene resulted in more herbicide-tolerant calli than the use of nonautonomous donor DNA. The ratio of calli with a site-specific insertion of PAT at the IPK1 locus was much higher, however, when nonautonomous donor DNA was used. Importantly, insertion of the PAT gene into the IPK1 ZFN target site will result in the knockout of the IPK1 gene. The authors successfully produced an IPK1 knockout maize strain; furthermore, they showed decreased phytate and increased inorganic phosphate levels, as expected from the loss of the IPK1 enzyme.

More recently, efficient ZFN-mediated gene knockouts via NHEJ in*Arabidopsis* were reported (Table [1](#Tab1){ref-type="table"}). In one study, ZFNs targeting the ADH1 and TT4 genes were developed and constructed in an estrogen-inducible expression system (Zhang et al. [@CR74]). ADH1- and TT4-specific ZFN pairs were introduced into wild-type*Arabidopsis* plants by the*Agrobacterium* floral dip method. Transgenic plants containing ZFN constructs were selected; ZFN expression was induced with estradiol for ten days during germination. Subsequent analysis of somatic mutations in T1 seedlings revealed that the ZFNs efficiently induced mutations in the ADH1 and TT4 target sites with estimated rates of 16 and 7%, respectively. Importantly, these mutant T1 seedlings also showed a high frequency of germinal transmission of the ADH1 and TT4 mutations. In an independent study, ZFNs targeting the ABA-INSENSITIVE4 (ABI4) gene were developed and transferred to*Arabidopsis* via*Agrobacterium*-mediated transformation (Osakabe et al. [@CR45]). Expression of the transferred ABI4 ZFNs was under the control of the*Arabidopsis* heat-shock protein HSP18.2 gene promoter. When ABI4 ZFN expression was induced by heat shock in nine transgenic plants, mutations at the ABI4 ZFN target site were induced at various rates ranging from 0.26 to 2.86%. In subsequent analysis, the authors successfully generated homozygous ABI4 knockout progenies from these T1 plants and showed that these plants exhibited the expected phenotypes of ABA and glucose insensitivity. These two studies establish ZFN-mediated gene knockout via NHEJ as an efficient and reliable approach in*Arabidopsis*.

Conclusion {#Sec9}
==========

With recent successes in the application of ZFN technology to model plants and crops, ZFN could represent a reliable and robust method for targeted genome modification, which has been an elusive goal for plant researchers so far. The successful implementation of ZFN technology generally requires reliable sources of target-specific ZFNs, efficient methods of delivering and expressing ZFNs, sensitive methods of validating the activity of ZFNs, and robust strategies to isolate engineered organisms. Fortunately, many of the above requirements have already been established in previous efforts to use ZFNs in cultured cells and animals, and they are easily applicable to plants. More efforts to adapt ZFN technology for various well-established gene delivery and expression systems in plants, as described in a recent report on the efficient delivery of ZFNs using tobacco rattle virus (TRV), may greatly broaden the spectrum of plants to which ZFN-mediated genome engineering can be efficiently applied (Marton et al. [@CR36]).
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